93 related articles for article (PubMed ID: 9557247)
1. New Molecules of Importance in the Prevention and Treatment of Acne: A Systematic Patent Review (2016-2020).
Calderón-Pardo DE; Serafini MR; Alves IA; Aragón DM
Curr Med Chem; 2024; 31(21):3182-3197. PubMed ID: 37592768
[TBL] [Abstract][Full Text] [Related]
2. Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease.
Armillei MK; Lomakin IB; Del Rosso JQ; Grada A; Bunick CG
Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534705
[TBL] [Abstract][Full Text] [Related]
3. Tea Tree Oil: Properties and the Therapeutic Approach to Acne-A Review.
Nascimento T; Gomes D; Simões R; da Graça Miguel M
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371994
[TBL] [Abstract][Full Text] [Related]
4. Complementary therapies for acne vulgaris.
Cao H; Yang G; Wang Y; Liu JP; Smith CA; Luo H; Liu Y
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009436. PubMed ID: 25597924
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity.
Gupta A; Singh S; Kotla NG; Webster TJ
Int J Nanomedicine; 2015; 10():171-82. PubMed ID: 25565812
[TBL] [Abstract][Full Text] [Related]
6. Bacterial resistance to antibiotics in acne vulgaris: an in vitro study.
Hassanzadeh P; Bahmani M; Mehrabani D
Indian J Dermatol; 2008; 53(3):122-4. PubMed ID: 19882009
[TBL] [Abstract][Full Text] [Related]
7. [Management of acne vulgaris: focus on clindamycin and zinc].
Korting HC; Schöllmann C
Hautarzt; 2009 Jan; 60(1):42-7. PubMed ID: 19082570
[TBL] [Abstract][Full Text] [Related]
8. Topical antibacterial therapy for acne vulgaris.
Dreno B
Drugs; 2004; 64(21):2389-97. PubMed ID: 15481998
[TBL] [Abstract][Full Text] [Related]
9. Transdermal penetration of topical drugs used in the treatment of acne.
Krautheim A; Gollnick H
Clin Pharmacokinet; 2003; 42(14):1287-304. PubMed ID: 14606932
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
[TBL] [Abstract][Full Text] [Related]
12. Bacteriological resistance in acne: A call to action.
Dréno B
Eur J Dermatol; 2016 Apr; 26(2):127-32. PubMed ID: 26711531
[TBL] [Abstract][Full Text] [Related]
13. An overview of topical antibiotics for acne treatment.
Toyoda M; Morohashi M
Dermatology; 1998; 196(1):130-4. PubMed ID: 9557247
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance in the topical treatment of acne vulgaris.
Leyden JJ
Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
[TBL] [Abstract][Full Text] [Related]
15. Topical acne treatments in Europe and the issue of antimicrobial resistance.
Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
